Another venture capitalist speaks out on nanotech

from the Jurvetson-Wolfe-who's-next dept.
Also from TNT, a pointer to Steve Lenhert's About.com interview of Josh Wolfe, co-founder of Lux Capital. Excerpts: "I don't really think we have pure-play nanotechnology [public] stocks yet… In fact, don't be surprised if some of the more exciting developments and product introductions come from the incumbent chemical manufacturers: Dow, BASF, DuPont…A lot of the really exciting progress that we will see in the next few years will be happening at private startups that seek to emulate Zyvex's high-reaching goals…Nano companies have to be sure to balance the blue-sky research with real demand."